Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1988-05-10
1992-02-11
Weimar, Elizabeth C.
Chemistry: molecular biology and microbiology
Spore forming or isolating process
435 2, 43524025, 424 8591, 424577, 436808, A01N 102, C12N 502, C12P 2100, A61K 3900
Patent
active
050875701
ABSTRACT:
Highly concentrated hematopoietic stem cell compositions are provided which are substantially free of differentiated or dedicated hematopoietic cells. The cells are obtained by subtraction of cells having particular markers and selection of cells having particular markers. The resulting composition may be used to provide for individual or groups of hematopoietic lineages, to reconstitute stem cells of the host, and to identify an assay for a wide variety of hematopoietic growth factors.
REFERENCES:
patent: 4714680 (1987-12-01), Civin
Whitlock and Witte, 1982. PNAS 79:3608-3612, Long-term Culture of B Lymphocytes & Their Precursors . . . .
Basch et al., Cell Separation Using Positive Imnunoselective Techniques J. Immun. Methods 56:200 1983.
Stites et al. Basic & Clinical Immun. 5th Ed. p. 765.
Muller-Sieburg et al. 1986, Cell 44:653-662, Isolation of Two Early B-Lymphocyte Progenitors . . . .
Heimfeld Shelly
Muller-Sieburg Christa
Spangrude Gerald J.
Weissman Irving L.
Weimar Elizabeth C.
Ziska Suzanne
LandOfFree
Homogeneous mammalian hematopoietic stem cell composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Homogeneous mammalian hematopoietic stem cell composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Homogeneous mammalian hematopoietic stem cell composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-781568